FIG. 6.

Identification of an immunodominant Gag p24 HLA B∗27 epitope recognized by PBMC from three HLA-A∗02 B∗27-positive, HIV-1-infected subjects (subject N3: CD4⁺ T cell count, 497/mm³; plasma HIV-1 RNA load, 96,000 copies/ml; no concurrent antiretroviral therapy; subject N4: CD4⁺ T-cell count, 828/mm³; plasma HIV-1 RNA load, 50 copies/ml; no concurrent antiretroviral therapy; subject 1180: CD4⁺ T-cell count, 450/mm³; plasma HIV-1 RNA load, 2,379 copies/ml; concurrent treatment with IDV). Med, medium control.